Healthcare Industry News: Zimmer
News Release - December 1, 2008
Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer ReconstructiveWARSAW, Ind., Dec. 1 (Healthcare Sales & Marketing Network) -- Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH ) announced today that Jeffery A. McCaulley has joined the Company as President, Zimmer Reconstructive. He will have responsibility for the Company's activities in the reconstructive devices market, including Global Marketing and Americas Sales. Mr. McCaulley will report to David Dvorak, Zimmer Holdings President and Chief Executive Officer.
"Jeff has a tremendous background from a variety of health care settings and has established an outstanding record for building businesses," said Mr. Dvorak. "The Reconstructive category represents the great majority of our annual revenues and the market is expected to remain a growth opportunity given the aging of the population and other societal factors. We are excited to have Jeff apply his skills and experiences to our effort to build momentum and long-term leadership in reconstructive devices."
Mr. McCaulley most recently served as President and Chief Executive Officer of the Health Division of Wolters Kluwer, the leading provider of scientific information and workflow solutions for healthcare professionals, providers, payors and the pharmaceutical industry. Prior to joining Wolters Kluwer in 2004, he served three years as Vice President and General Manager of the Diabetes Division of Medtronic, Inc. He began his medical devices career in 1989 with General Electric Medical Systems, where he held positions of increasing responsibility in sales, marketing and general management, last serving as President and CEO of GE Clinical Services.
A graduate of the University of Cincinnati with a Bachelor of Science in Aerospace Engineering, Mr. McCaulley also holds an MBA from the Owen Graduate School of Management at Vanderbilt University.
"I'm looking forward to being a part of the Zimmer team and building on the Company's historic strengths in the reconstructive market," said Mr. McCaulley. "I regard this as an excellent opportunity to help Zimmer reassert itself and build for sustainable growth. Zimmer has tremendous assets -- great people, a legendary sales force and advanced technologies -- that can be leveraged for real competitive advantage."
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of approximately 8,500 employees worldwide.
For more information about Zimmer, visit www.Zimmer.com
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.
Source: Zimmer Holdings
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.